5-hydroxymilbemycin beta7,
CL 301,423,
CL 301423,
Cydectin,
milbemectin,
milbemycin,
milbemycin A3,
milbemycin A4,
milbemycin alpha1,
milbemycin alpha10,
milbemycin alpha11,
milbemycin alpha13,
milbemycin alpha14,
milbemycin alpha15,
milbemycin alpha2,
milbemycin alpha3,
milbemycin alpha4,
milbemycin alpha5,
milbemycin alpha6,
milbemycin alpha7,
milbemycin alpha8,
milbemycin alpha9,
milbemycin B,
milbemycin beta1,
milbemycin beta12,
milbemycin beta2,
milbemycin beta3,
milbemycin D,
milbemycins,
moxidectin,
Milbemycin A4,
MILBEMECTIN A4,
51596-11-3,
UNII-9BSH89E55Y,
9BSH89E55Y,
CHEBI:39229,
(2aE,4E,5'S,6R,6'R,8E,11R,13R,15S,17aR,20R,20aR,20bS)-6'-ethyl-20,20b-dihydroxy-5',6,8,19-tetramethyl-3',4',5',6,6',7,10,11,14,15,17a,20,20a,20b-tetradecahydro-2H,17H-spiro[11,15-methanofuro[4,3,2-pq][2,6]benzodioxacyclooctadecine-13,2'-pyran]-17-one,
Milbemycin B, 5-O-demethyl-28-deoxy-6,28-epoxy-25-ethyl-, (6R,25R)-,
DSSTox_CID_14742,
DSSTox_RID_79198,
DSSTox_GSID_34742,
CAS-NOCAS_34742,
SCHEMBL4139203,
CHEMBL2272397,
DTXSID4052760,
VOZIAWLUULBIPN-LRBNAKOISA-N,
Tox21_300945,
(6R,25R)-5-O-Demethyl-28-deoxy-6,28-epoxy-25-ethylmilbemycin B,
ZINC100076918,
NCGC00163780-02,
NCGC00163780-03,
NCGC00254847-01,
UNII-207B6WP2MZ component VOZIAWLUULBIPN-LRBNAKOISA-N,
Milbemectin (mixture of 70% Milbemcin A4, 30% Milbemycin A3),
Milbemectin A4 10 microg/mL in Acetonitrile. Short expiry date due to chemical nature of component(s),
Milbemectin,
MILBEMECTINA4,
C32H46O7,
C32-H46-O7,
CID9959038,